Monocyclic heterocycles as kinase inhibitors
US7989477B2 · kind B2 · utility
3Cited by
35References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2010 |
| Grant date | Aug 2, 2011 |
| Priority date | — |
| Expiry date | Mar 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds having the formulaand methods for using them for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.